MED Stock Overview
Igeamed S.p.A. provides consulting, engineering, training, and medical services.
Igeamed S.p.A. Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||€2.50|
|52 Week High||€2.50|
|52 Week Low||€2.50|
|1 Month Change||0%|
|3 Month Change||0%|
|1 Year Change||n/a|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||66.67%|
Recent News & Updates
|MED||IT Professional Services||IT Market|
Return vs Industry: Insufficient data to determine how MED performed against the Italian Professional Services industry.
Return vs Market: Insufficient data to determine how MED performed against the Italian Market.
|MED Average Weekly Movement||n/a|
|Professional Services Industry Average Movement||5.0%|
|Market Average Movement||4.8%|
|10% most volatile stocks in IT Market||6.9%|
|10% least volatile stocks in IT Market||2.9%|
Stable Share Price: Insufficient data to determine MED's volatility over the past 3 months.
Volatility Over Time: Insufficient data to determine MED's volatility change over the past year.
About the Company
Igeamed S.p.A. provides consulting, engineering, training, and medical services. The company offers EHS consulting services, such as health and safety, environmental, and energy management; engineering services, including process safety, maintenance engineering, safety engineering, and infrastructure engineering; and corporate healthcare services comprising occupational medicine, workplace health promotion, and corporate welfare, as well as consultancy services related to green power projects. It also provides business assurance, product control and development, infrastructure control, and innovation and smart industry solutions; training solutions for risk management and managerial competence comprising EHS Future Academy, Corporate Future Academy, and Business Assurance Academy; and digital software solutions for the safety in the workplace, risk assessment, and management of corporate assets.
Igeamed S.p.A. Fundamentals Summary
|MED fundamental statistics|
Is MED overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|MED income statement (TTM)|
|Cost of Revenue||€7.47m|
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
|Earnings per share (EPS)||0.036|
|Net Profit Margin||1.02%|
How did MED perform over the long term?See historical performance and comparison